Rankings
▼
Calendar
BEAM Q3 2025 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BEAM
Beam Therapeutics Inc.
$3B
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$10M
-32.0% YoY
Gross Profit
-$100M
-1031.9% margin
Operating Income
-$127M
-1307.6% margin
Net Income
-$113M
-1162.4% margin
EPS (Diluted)
$-1.10
QoQ Revenue Growth
+14.6%
Cash Flow
Operating Cash Flow
-$81M
Free Cash Flow
-$86M
Stock-Based Comp.
$23M
Balance Sheet
Total Assets
$1.3B
Total Liabilities
$345M
Stockholders' Equity
$966M
Cash & Equivalents
$268M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$10M
$14M
-32.0%
Gross Profit
-$100M
-$80M
-25.1%
Operating Income
-$127M
-$107M
-19.1%
Net Income
-$113M
-$97M
-16.6%
← FY 2025
All Quarters
Q4 2025 →